Cannabis dependence
ICD-10 F12.2 is a billable code used to indicate a diagnosis of cannabis dependence.
Cannabis dependence is characterized by a problematic pattern of cannabis use leading to clinically significant impairment or distress. This condition is marked by a strong desire or urge to use cannabis, tolerance to its effects, and withdrawal symptoms when not using. Individuals may continue to use cannabis despite experiencing social, occupational, or interpersonal problems caused or exacerbated by its use. Symptoms of withdrawal can include irritability, insomnia, decreased appetite, and anxiety. The diagnosis is made based on the criteria outlined in the DSM-5, which includes a range of behavioral, psychological, and physiological symptoms. Treatment often involves behavioral therapies, counseling, and support groups, with some patients benefiting from pharmacotherapy to manage withdrawal symptoms. Understanding the nuances of cannabis dependence is crucial for effective treatment and management, as well as for accurate coding and billing practices.
Detailed history of substance use, treatment history, and psychosocial factors.
Patients seeking help for cannabis use, often with co-occurring mental health issues.
Consideration of legal implications and patient education on cannabis use.
Comprehensive mental health assessment, including mood and anxiety evaluations.
Patients presenting with anxiety or mood disorders exacerbated by cannabis use.
Differentiating between primary psychiatric disorders and substance-induced symptoms.
Used during initial evaluation of cannabis dependence.
Comprehensive assessment including history and current functioning.
Addiction specialists may require additional details on substance use history.
Cannabis dependence (F12.2) indicates a more severe level of impairment and includes withdrawal symptoms, while cannabis use disorder can range from mild to severe, with F12.2 specifically denoting dependence.
